# A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

> **NCT06700070** · EARLY_PHASE1 · RECRUITING · sponsor: **Pure Biologics S.A.** · enrollment: 12 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Soft Tissue Sarcoma Adult
- Triple Negative Breast Cancer

## Interventions

- **DRUG:** PBA-0111

## Key facts

- **NCT ID:** NCT06700070
- **Lead sponsor:** Pure Biologics S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-27
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06700070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06700070, "A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06700070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*